(Q33718699)

28 July 2017

title

Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome (English)

1 reference

inflammatory bowel diseases

28 July 2017

main subject

0 references

irritable bowel syndrome

1 reference

inferred from title

author name string

Anastassios C Manolakis

1

1 reference

28 July 2017

Andreas N Kapsoritakis

2

1 reference

28 July 2017

Panagiotis Georgoulias

3

1 reference

28 July 2017

Chara Tzavara

4

1 reference

28 July 2017

Varvara Valotassiou

5

1 reference

28 July 2017

Anastasia Kapsoritaki

6

1 reference

28 July 2017

Spyros P Potamianos

7

1 reference

28 July 2017

publication date

14 October 2010

1 reference

28 July 2017

1 reference

28 July 2017

volume

10

1 reference

28 July 2017

page(s)

118

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-230x-10-118

28 July 2017

exact match

0 references

cites work

The functional-organic dichotomy: postinfectious irritable bowel syndrome and inflammatory bowel disease-irritable bowel syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964606

Review of fecal biomarkers in inflammatory bowel disease

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964606

Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964606

New serological markers in inflammatory bowel disease are associated with complicated disease behaviour

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964606

Matrix metalloproteinases in inflammatory bowel disease: boon or a bane?

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964606

Smoking and inflammatory bowel disease: a meta-analysis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964606

S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964606

Calcium-dependent and -independent interactions of the S100 protein family.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964606

Laboratory markers in IBD: useful, magic, or unnecessary toys?

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964606

Serologic markers in inflammatory bowel disease

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964606

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964606

How accurate are clinical activity indices for scoring of disease activity in inflammatory bowel disease (IBD)?

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964606

Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964606

Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964606

A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964606

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964606

Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964606

Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease

14 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-230X-10-118

Fecal S100A12: a novel noninvasive marker in children with Crohn's disease

21 January 2018

1 reference

12 December 2020

Guidelines--Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders

1 reference

12 December 2020

Quantification of S100A12 (EN-RAGE) in blood varies with sampling method, calcium and heparin

1 reference

12 December 2020

Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy

1 reference

12 December 2020

Accuracy of four fecal assays in the diagnosis of colitis

1 reference

12 December 2020

Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease

1 reference

12 December 2020

Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies

1 reference

12 December 2020

Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices

1 reference

12 December 2020

Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children

1 reference

12 December 2020

Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome

1 reference

12 December 2020

Clinical utility of the assessment of fecal calprotectin in Leśniowski-Crohn's disease

1 reference

12 December 2020

A systematic prospective comparison of noninvasive disease activity indices in ulcerative colitis

1 reference

12 December 2020

Vascular endothelial growth factor in inflammatory bowel disease

1 reference

12 December 2020

Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-230X-10-118

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference